CAS 904309-12-2

6-Bromo-2-[3-(trifluoromethyl)[2,3′-bipyridin]-6′-yl]-1H-benzimidazole

Description:

6-Bromo-2-[3-(trifluoromethyl)[2,3′-bipyridin]-6′-yl]-1H-benzimidazole is a complex organic compound characterized by its unique structural features, which include a benzimidazole core and a bipyridine moiety. The presence of a bromine atom and a trifluoromethyl group contributes to its chemical reactivity and potential biological activity. This compound is typically used in medicinal chemistry and research due to its potential as a pharmacological agent. Its molecular structure suggests it may exhibit interesting interactions with biological targets, possibly influencing enzyme activity or receptor binding. The trifluoromethyl group enhances lipophilicity, which can improve membrane permeability, while the bipyridine structure may facilitate coordination with metal ions. Additionally, the compound's stability and solubility characteristics are influenced by the presence of halogen substituents. Overall, 6-Bromo-2-[3-(trifluoromethyl)[2,3′-bipyridin]-6′-yl]-1H-benzimidazole represents a valuable scaffold in drug discovery and development, warranting further investigation into its pharmacological properties.

Formula: C₁₈H₁₀BrF₃N₄

Synonyms:

• [Synonyms]

DWP-05195

CAS: 904309-12-2

DWP-05195 is a TRPV1 antagonist capable of inhibiting pain signal transduction. Additionally, it induces ER stress-dependent apoptosis in human ovarian cancer cells via the ROS-p38-CHOP pathway.

Formula: C₁₈H₁₀BrF₃N₄

Color and Shape: Solid

Molecular weight: 419.2

Ref: TM-T201755